Your Strategic Thought Partner.

We drive execution and deliver results for Market Access and Pricing Functions

Your Growth, Our Mission

At Tak BioSuisse, we help life sciences companies enter and grow in Switzerland through expert market access pricing, drug development, and partnership strategies designed to drive maximize ROI with precision.

Your Strategic Thought Partner.

We drive execution and deliver results for Market Access and Pricing Functions

Your Growth, Our Mission

Your Strategic Thought Partner.

We drive execution and deliver results for Market Access and Pricing Functions

Your Growth, Our Mission

18+

Years of Experience

50+

Clients Served

20+

Therapeutic Areas

10+

Drugs Approved

18+

Years of Experience

50+

Clients Served

20+

Therapeutic Areas

10+

Drugs Approved

At Tak BioSuisse, we help life sciences companies enter and grow in Switzerland through expert market access pricing, drug development, and partnership strategies designed to drive maximize ROI with precision.

At Tak BioSuisse, we help life sciences companies enter and grow in Switzerland through expert market access pricing, drug development, and partnership strategies designed to drive maximize ROI with precision.

Our Services

How Can we
Help You?

Providing Strategic Advisory to Market Access and Pricing Teams, from Early Development to Launch and Life Cycle Management

HTA, Access & Pricing Advisory

Early HTA Strategy and Execution across European and Global markets, alongside Comprehensive Pricing Research and EU Advisory Boards

Life Cycle Management

Loss of Exclusivity (LoE) planning and execution, paired with Contracting and Tender Management Strategy across the asset lifecycle.

EU HTAR Educational Programmes

Instructor-led organisational training to prepare for EU HTAR, decode complex requirements, and effectively structure workflows.

TLRlens – Precision Driven Literature Intelligence and Synthesis

TLRlens is an internal literature intelligence platform developed by TAK BioSuisse to enhance the quality and efficiency of evidence review. It provides a standardized framework for targeted literature searches, screening, and synthesis, ensuring scientific rigor and traceability throughout the research process.

Operational Support, AI & Analytics

Fractional Program and Project Management Support to fill intermediate resource gaps, and the design of fit-for-purpose AI solutions.

HTA Compass™ Platform

A digital SaaS platform supporting seamless JCA dossier preparation and submission workflows with AI-enabled insights.

Integrated Evidence Generation

Integrated Evidence Generation Planning (IEGP) designed for Impact, featuring AI-assisted post-IEGP execution and global coordination.

Meet our amazing team.

We are a team of strategists, designers, and innovators passionate about helping agencies grow.
  • Founder and Managing Director
    Sameera Tak

    Managing Director & Founder

  • Carl Fredrik Lindberg

    Consulting Partner

  • Catherine

    Consulting Partner

  • Keerthi Aluru

    Project Manager

  • Noel Veigas

    Full-Stack Developer

  • Andrea

    Consulting Partner

At Tak BioSuisse, we help life sciences companies enter and grow in Switzerland through expert market access pricing, drug development, and partnership strategies designed to drive maximize ROI with precision.

Our Services

How Can we
Help You?

Providing Strategic Advisory to Market Access and Pricing Teams, from Early Development to Launch and Life Cycle Management

HTA, Access & Pricing Advisory

Early HTA Strategy and Execution across European and Global markets, alongside Comprehensive Pricing Research and EU Advisory Boards

Life Cycle Management

Loss of Exclusivity (LoE) planning and execution, paired with Contracting and Tender Management Strategy across the asset lifecycle.

EU HTAR Educational Programmes

Instructor-led organisational training to prepare for EU HTAR, decode complex requirements, and effectively structure workflows.

Integrated Evidence Generation

Integrated Evidence Generation Planning (IEGP) designed for Impact, featuring AI-assisted post-IEGP execution and global coordination.

Operational Support, AI & Analytics

Fractional Program and Project Management Support to fill intermediate resource gaps, and the design of fit-for-purpose AI solutions.

HTA Compass™ Platform

A digital SaaS platform supporting seamless JCA dossier preparation and submission workflows with AI-enabled insights.

TLRlens – Precision Driven Literature Intelligence and Synthesis

TLRlens is an internal literature intelligence platform developed by TAK BioSuisse to enhance the quality and efficiency of evidence review. It provides a standardized framework for targeted literature searches, screening, and synthesis, ensuring scientific rigor and traceability throughout the research process.

Our Services

How Can we
Help You?

Providing Strategic Advisory to Market Access and Pricing Teams, from Early Development to Launch and Life Cycle Management

HTA, Access & Pricing Advisory

Early HTA Strategy and Execution across European and Global markets, alongside Comprehensive Pricing Research and EU Advisory Boards

Life Cycle Management

Loss of Exclusivity (LoE) planning and execution, paired with Contracting and Tender Management Strategy across the asset lifecycle.

EU HTAR Educational Programmes

Instructor-led organisational training to prepare for EU HTAR, decode complex requirements, and effectively structure workflows.

TLRlens – Precision Driven Literature Intelligence and Synthesis

TLRlens is an internal literature intelligence platform developed by TAK BioSuisse to enhance the quality and efficiency of evidence review. It provides a standardized framework for targeted literature searches, screening, and synthesis, ensuring scientific rigor and traceability throughout the research process.

Operational Support, AI & Analytics

Fractional Program and Project Management Support to fill intermediate resource gaps, and the design of fit-for-purpose AI solutions.

HTA Compass™ Platform

A digital SaaS platform supporting seamless JCA dossier preparation and submission workflows with AI-enabled insights.

Integrated Evidence Generation

Integrated Evidence Generation Planning (IEGP) designed for Impact, featuring AI-assisted post-IEGP execution and global coordination.

Meet our amazing team.

We are a team of strategists, designers, and innovators passionate about helping agencies grow.
  • Founder and Managing Director
    Sameera Tak

    Managing Director & Founder

  • Carl Fredrik Lindberg

    Consulting Partner

  • Catherine

    Consulting Partner

  • Keerthi Aluru

    Project Manager

  • Noel Veigas

    Full-Stack Developer

  • Andrea

    Consulting Partner

Strategic Pathways
for Better Patient Lives

Let’s achieve your goals together

Tak Biosuisse 2026

Strategic Pathways
for Better Patient Lives

Let’s achieve your goals together

Tak Biosuisse 2026

Strategic Pathways
for Better Patient Lives

Let’s achieve your goals together

Tak Biosuisse 2026

Chatbot